November 14, 2012, Horsham, PA—Specialty biopharma marketing agency Dudnyk has been awarded business from Nicox, Inc., the US subsidiary of Nicox, SA. Nicox engaged Dudnyk to support the marketing efforts to eye care professionals for the launch of AdenoPlus™, the first and only FDA-cleared, CLIA-waived, rapid, point-of-care diagnostic test that aids in the differential diagnosis of acute conjunctivitis.
Jason Menzo, who previously worked with the agency to develop an award-winning promotion campaign for another eye care product, hired Dudnyk when he was appointed Director of Marketing for Nicox. Mr. Menzo is responsible for introducing Nicox Ophthalmic Diagnostics and its first product, AdenoPlus™, to eye care professionals.
“I am excited to be working with Dudnyk to launch AdenoPlus™ in the US. There is no other agency that I would even consider having support me and my team,” Menzo said. “My successful history working with Dudnyk was marked with several incredible milestones in the sale of our previous brand, and I am confident that Dudnyk’s unparalleled strategic vigor and creative power will pay huge dividends for the launch of AdenoPlus™. I truly view them as an extension of my brand team.”
“We are thrilled to be working with Jason again as he launches Nicox’s first commercial product in the US. Dudnyk will be working with his team to develop the marketing strategy, product positioning, branding, and messaging for AdenoPlus™. We will also be providing support for several corporate initiatives,” said Frank X. Powers, Dudnyk’s president. Dudnyk is widely respected for its bold, unparalleled marketing excellence. The Dudnyk team that led the previous campaign is reconvening to work with Jason Menzo on AdenoPlus™. The team is led by Scott Harper, with support from Laurie Bartolomeo, Creative Director, Copy, and John Kemble, Creative Director, Art.
